These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 28116998)

  • 1. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking and structure-based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani.
    Singh S; Vijaya Prabhu S; Suryanarayanan V; Bhardwaj R; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2016 Nov; 34(11):2367-86. PubMed ID: 26551589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout.
    Bhardwaj R; Das M; Singh S; Chiranjivi AK; Prabhu SV; Singh SK; Dubey VK
    Eur J Pharm Sci; 2017 May; 102():156-160. PubMed ID: 28279761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
    Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
    Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening to identify Leishmania braziliensis N-myristoyltransferase inhibitors: pharmacophore models, docking, and molecular dynamics.
    de Carvalho Gallo JC; de Mattos Oliveira L; Araújo JSC; Santana IB; Dos Santos Junior MC
    J Mol Model; 2018 Aug; 24(9):260. PubMed ID: 30159742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors.
    Muthusamy K; Singh KhD; Chinnasamy S; Nagamani S; Krishnasamy G; Thiyagarajan C; Premkumar P; Anusuyadevi M
    Interdiscip Sci; 2013 Jun; 5(2):119-26. PubMed ID: 23740393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
    Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
    J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening.
    Sindhu T; Srinivasan P
    Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).
    Kant V; Vijayakumar S; Sahoo GC; Ali V; Singh K; Chaudhery SS; Das P
    J Biomol Struct Dyn; 2019 Feb; 37(2):481-492. PubMed ID: 29415627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
    Elseginy SA
    J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
    Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
    Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel inhibitors of dipeptidylcarboxypeptidase of Leishmania donovani via ligand-based virtual screening and biological evaluation.
    Gangwar S; Baig MS; Shah P; Biswas S; Batra S; Siddiqi MI; Goyal N
    Chem Biol Drug Des; 2012 Feb; 79(2):149-56. PubMed ID: 22014034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
    Kaur M; Silakari O
    J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.